Brief: Galera Schedules Type A Meeting With FDA To Discuss Next Steps For Inflammation Disease Drug

Obsidian Therapeutics

18/09/2023 12:16

Sept 18 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA SCHEDULES TYPE A MEETING WITH FDA TO DISCUSS NEXT
STEPS
FOR AVASOPASEM

Source text for Eikon:  ID:nGNX7hmHNL 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))